ID   DPOLA_HUMAN             Reviewed;        1462 AA.
AC   P09884; Q86UQ7;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 2.
DT   12-APR-2017, entry version 176.
DE   RecName: Full=DNA polymerase alpha catalytic subunit;
DE            EC=2.7.7.7;
DE   AltName: Full=DNA polymerase alpha catalytic subunit p180;
GN   Name=POLA1; Synonyms=POLA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3359994;
RA   Wong S.W., Wahl A.F., Yuan P.-M., Arai N., Pearson B.E., Arai K.,
RA   Korn D., Hunkapiller M.W., Wang T.S.-F.;
RT   "Human DNA polymerase alpha gene expression is cell proliferation
RT   dependent and its primary structure is similar to both prokaryotic and
RT   eukaryotic replicative DNA polymerases.";
RL   EMBO J. 7:37-47(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-8.
RX   PubMed=2005899; DOI=10.1128/MCB.11.4.2081;
RA   Pearson B.E., Nasheuer H.-P., Wang T.S.-F.;
RT   "Human DNA polymerase alpha gene: sequences controlling expression in
RT   cycling and serum-stimulated cells.";
RL   Mol. Cell. Biol. 11:2081-2095(1991).
RN   [4]
RP   PROTEIN SEQUENCE OF 19-37 AND 1405-1426, AND PROTEOLYTIC PROCESSING AT
RP   LYS-124.
RX   PubMed=2243771; DOI=10.1093/nar/18.21.6231;
RA   Hsi K.-L., Copeland W.C., Wang T.S.-F.;
RT   "Human DNA polymerase alpha catalytic polypeptide binds ConA and RCA
RT   and contains a specific labile site in the N-terminus.";
RL   Nucleic Acids Res. 18:6231-6237(1990).
RN   [5]
RP   INTERACTION WITH SV40 LARGE T ANTIGEN.
RX   PubMed=3025630; DOI=10.1128/MCB.6.11.4077;
RA   Smale S.T., Tjian R.;
RT   "T-antigen-DNA polymerase alpha complex implicated in simian virus 40
RT   DNA replication.";
RL   Mol. Cell. Biol. 6:4077-4087(1986).
RN   [6]
RP   INTERACTION WITH HHV-1 UL9 PROTEIN.
RX   PubMed=7644508; DOI=10.1073/pnas.92.17.7882;
RA   Lee S.S., Dong Q., Wang T.S., Lehman I.R.;
RT   "Interaction of herpes simplex virus 1 origin-binding protein with DNA
RT   polymerase alpha.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7882-7886(1995).
RN   [7]
RP   INTERACTION WITH RPA1.
RX   PubMed=9214288; DOI=10.1021/bi970473r;
RA   Braun K.A., Lao Y., He Z., Ingles C.J., Wold M.S.;
RT   "Role of protein-protein interactions in the function of replication
RT   protein A (RPA): RPA modulates the activity of DNA polymerase alpha by
RT   multiple mechanisms.";
RL   Biochemistry 36:8443-8454(1997).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH PARP1.
RX   PubMed=9518481; DOI=10.1093/nar/26.8.1891;
RA   Dantzer F., Nasheuer H.P., Vonesch J.L., de Murcia G.,
RA   Menissier-de Murcia J.;
RT   "Functional association of poly(ADP-ribose) polymerase with DNA
RT   polymerase alpha-primase complex: a link between DNA strand break
RT   detection and DNA replication.";
RL   Nucleic Acids Res. 26:1891-1898(1998).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186; SER-190 AND
RP   SER-209, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   INTERACTION WITH MCM10.
RX   PubMed=19608746; DOI=10.1074/jbc.M109.020438;
RA   Warren E.M., Huang H., Fanning E., Chazin W.J., Eichman B.F.;
RT   "Physical interactions between Mcm10, DNA, and DNA polymerase alpha.";
RL   J. Biol. Chem. 284:24662-24672(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-174 AND SER-186, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-174; SER-186; SER-190
RP   AND SER-209, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186 AND SER-209, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-186; SER-190; SER-209
RP   AND THR-406, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   INVOLVEMENT IN PDR, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=27019227; DOI=10.1038/ni.3409;
RA   Starokadomskyy P., Gemelli T., Rios J.J., Xing C., Wang R.C., Li H.,
RA   Pokatayev V., Dozmorov I., Khan S., Miyata N., Fraile G., Raj P.,
RA   Xu Z., Xu Z., Ma L., Lin Z., Wang H., Yang Y., Ben-Amitai D.,
RA   Orenstein N., Mussaffi H., Baselga E., Tadini G., Grunebaum E.,
RA   Sarajlija A., Krzewski K., Wakeland E.K., Yan N., de la Morena M.T.,
RA   Zinn A.R., Burstein E.;
RT   "DNA polymerase-alpha regulates the activation of type I interferons
RT   through cytosolic RNA:DNA synthesis.";
RL   Nat. Immunol. 17:495-504(2016).
RN   [17]
RP   STRUCTURE BY NMR OF 1345-1382.
RX   PubMed=14499601; DOI=10.1016/S1570-9639(03)00266-8;
RA   Evanics F., Maurmann L., Yang W.W., Bose R.N.;
RT   "Nuclear magnetic resonance structures of the zinc finger domain of
RT   human DNA polymerase-alpha.";
RL   Biochim. Biophys. Acta 1651:163-171(2003).
CC   -!- FUNCTION: Plays an essential role in the initiation of DNA
CC       replication. During the S phase of the cell cycle, the DNA
CC       polymerase alpha complex (composed of a catalytic subunit
CC       POLA1/p180, a regulatory subunit POLA2/p70 and two primase
CC       subunits PRIM1/p49 and PRIM2/p58) is recruited to DNA at the
CC       replicative forks via direct interactions with MCM10 and WDHD1.
CC       The primase subunit of the polymerase alpha complex initiates DNA
CC       synthesis by oligomerising short RNA primers on both leading and
CC       lagging strands. These primers are initially extended by the
CC       polymerase alpha catalytic subunit and subsequently transferred to
CC       polymerase delta and polymerase epsilon for processive synthesis
CC       on the lagging and leading strand, respectively. The reason this
CC       transfer occurs is because the polymerase alpha has limited
CC       processivity and lacks intrinsic 3' exonuclease activity for
CC       proofreading error, and therefore is not well suited for
CC       replicating long complexes. In the cytosol, responsible for a
CC       substantial proportion of the physiological concentration of
CC       cytosolic RNA:DNA hybrids, which are necessary to prevent
CC       spontaneous activation of type I interferon responses
CC       (PubMed:27019227). {ECO:0000269|PubMed:27019227,
CC       ECO:0000269|PubMed:9518481}.
CC   -!- CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) =
CC       diphosphate + DNA(n+1).
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC         Evidence={ECO:0000250};
CC       Note=Binds 1 [4Fe-4S] cluster. {ECO:0000250};
CC   -!- SUBUNIT: The DNA polymerase alpha complex is composed of four
CC       subunits: the catalytic subunit POLA1, the regulatory subunit
CC       POLA2, and the small and the large primase subunits PRIM1 and
CC       PRIM2 respectively. Interacts with PARP1; this interaction
CC       functions as part of the control of replication fork progression.
CC       Interacts with MCM10 and WDHD1; these interactions recruit the
CC       polymerase alpha complex to the pre-replicative complex bound to
CC       DNA. Interacts with RPA1; this interaction stabilizes the
CC       replicative complex and reduces the misincorporation rate of DNA
CC       polymerase alpha by acting as a fidelity clamp. Interacts with
CC       SV40 Large T antigen; this interaction allows viral DNA
CC       replication. Interacts with herpes simplex virus 1 (HHV-1)
CC       replication origin-binding protein UL9.
CC       {ECO:0000269|PubMed:19608746, ECO:0000269|PubMed:3025630,
CC       ECO:0000269|PubMed:7644508, ECO:0000269|PubMed:9214288,
CC       ECO:0000269|PubMed:9518481}.
CC   -!- INTERACTION:
CC       P03070:- (xeno); NbExp=6; IntAct=EBI-850026, EBI-617698;
CC       P04014:E1 (xeno); NbExp=2; IntAct=EBI-850026, EBI-7014446;
CC       P27694:RPA1; NbExp=2; IntAct=EBI-850026, EBI-621389;
CC       P10193:UL9 (xeno); NbExp=4; IntAct=EBI-850026, EBI-8596799;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:27019227}.
CC       Cytoplasm, cytosol {ECO:0000269|PubMed:27019227}. Note=In the
CC       cytosol, colocalizes with RNA:DNA hybrids with a speckled pattern.
CC       {ECO:0000269|PubMed:27019227}.
CC   -!- DOMAIN: The CysB motif binds 1 4Fe-4S cluster and is required for
CC       the formation of polymerase complexes. {ECO:0000250}.
CC   -!- PTM: A 165 kDa form is probably produced by proteolytic cleavage
CC       at Lys-124. {ECO:0000269|PubMed:2243771}.
CC   -!- DISEASE: Pigmentary disorder, reticulate, with systemic
CC       manifestations, X-linked (PDR) [MIM:301220]: A X-linked recessive
CC       disorder characterized by recurrent infections and sterile
CC       inflammation in various organs. Diffuse skin hyperpigmentation
CC       with a distinctive reticulate pattern is universally evident by
CC       early childhood. This is later followed in many patients by
CC       hypohidrosis, corneal inflammation and scarring, enterocolitis
CC       that resembles inflammatory bowel disease, and recurrent urethral
CC       strictures. Melanin and amyloid deposition is present in the
CC       dermis. Affected males also have a characteristic facies with
CC       frontally upswept hair and flared eyebrows. Female carriers have
CC       only restricted pigmentary changes along Blaschko's lines.
CC       {ECO:0000269|PubMed:27019227}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry. XLPDR is
CC       caused by a recurrent intronic mutation that results in
CC       missplicing and reduced POLA1 expression. This leads to a decrease
CC       in cytosolic RNA:DNA hybrids and constitutive activation of type I
CC       interferon responses, but has no effect on cell replication.
CC       {ECO:0000269|PubMed:27019227}.
CC   -!- MISCELLANEOUS: In eukaryotes there are five DNA polymerases:
CC       alpha, beta, gamma, delta, and epsilon which are responsible for
CC       different reactions of DNA synthesis.
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-B family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pola/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X06745; CAA29920.1; -; mRNA.
DR   EMBL; AY275833; AAP13534.1; -; Genomic_DNA.
DR   EMBL; M64481; AAA52318.1; -; Genomic_DNA.
DR   CCDS; CCDS14214.1; -.
DR   PIR; S00257; DJHUAC.
DR   RefSeq; NP_058633.2; NM_016937.3.
DR   UniGene; Hs.567319; -.
DR   PDB; 1K0P; NMR; -; A=1347-1377.
DR   PDB; 1K18; NMR; -; A=1347-1377.
DR   PDB; 1N5G; NMR; -; A=1345-1382.
DR   PDB; 4Q5V; X-ray; 2.52 A; A/E=336-1257.
DR   PDB; 4QCL; X-ray; 2.20 A; A=336-1257.
DR   PDB; 4Y97; X-ray; 2.51 A; B/D/F/H=1265-1444.
DR   PDB; 5EXR; X-ray; 3.60 A; C/G=335-1462.
DR   PDB; 5IUD; X-ray; 3.30 A; A/D/G/J=338-1255.
DR   PDBsum; 1K0P; -.
DR   PDBsum; 1K18; -.
DR   PDBsum; 1N5G; -.
DR   PDBsum; 4Q5V; -.
DR   PDBsum; 4QCL; -.
DR   PDBsum; 4Y97; -.
DR   PDBsum; 5EXR; -.
DR   PDBsum; 5IUD; -.
DR   ProteinModelPortal; P09884; -.
DR   SMR; P09884; -.
DR   BioGrid; 111418; 54.
DR   IntAct; P09884; 12.
DR   MINT; MINT-1517478; -.
DR   STRING; 9606.ENSP00000368349; -.
DR   BindingDB; P09884; -.
DR   ChEMBL; CHEMBL1828; -.
DR   DrugBank; DB00242; Cladribine.
DR   DrugBank; DB00631; Clofarabine.
DR   DrugBank; DB01073; Fludarabine.
DR   DrugBank; DB01280; Nelarabine.
DR   iPTMnet; P09884; -.
DR   PhosphoSitePlus; P09884; -.
DR   BioMuta; POLA1; -.
DR   DMDM; 60392197; -.
DR   EPD; P09884; -.
DR   MaxQB; P09884; -.
DR   PaxDb; P09884; -.
DR   PeptideAtlas; P09884; -.
DR   PRIDE; P09884; -.
DR   Ensembl; ENST00000379059; ENSP00000368349; ENSG00000101868.
DR   GeneID; 5422; -.
DR   KEGG; hsa:5422; -.
DR   UCSC; uc004dbl.4; human.
DR   CTD; 5422; -.
DR   DisGeNET; 5422; -.
DR   GeneCards; POLA1; -.
DR   H-InvDB; HIX0028476; -.
DR   HGNC; HGNC:9173; POLA1.
DR   HPA; CAB012274; -.
DR   HPA; HPA002947; -.
DR   MalaCards; POLA1; -.
DR   MIM; 301220; phenotype.
DR   MIM; 312040; gene.
DR   neXtProt; NX_P09884; -.
DR   OpenTargets; ENSG00000101868; -.
DR   PharmGKB; PA162399856; -.
DR   eggNOG; KOG0970; Eukaryota.
DR   eggNOG; COG0417; LUCA.
DR   GeneTree; ENSGT00550000074891; -.
DR   HOGENOM; HOG000163524; -.
DR   HOVERGEN; HBG080008; -.
DR   InParanoid; P09884; -.
DR   KO; K02320; -.
DR   PhylomeDB; P09884; -.
DR   TreeFam; TF103001; -.
DR   Reactome; R-HSA-113501; Inhibition of replication initiation of damaged DNA by RB1/E2F1.
DR   Reactome; R-HSA-113510; E2F mediated regulation of DNA replication.
DR   Reactome; R-HSA-174411; Polymerase switching on the C-strand of the telomere.
DR   Reactome; R-HSA-174430; Telomere C-strand synthesis initiation.
DR   Reactome; R-HSA-68952; DNA replication initiation.
DR   Reactome; R-HSA-68962; Activation of the pre-replicative complex.
DR   Reactome; R-HSA-69091; Polymerase switching.
DR   Reactome; R-HSA-69166; Removal of the Flap Intermediate.
DR   Reactome; R-HSA-69183; Processive synthesis on the lagging strand.
DR   Reactome; R-HSA-69205; G1/S-Specific Transcription.
DR   ChiTaRS; POLA1; human.
DR   EvolutionaryTrace; P09884; -.
DR   GeneWiki; Polymerase_(DNA_directed),_alpha_1; -.
DR   GenomeRNAi; 5422; -.
DR   PRO; PR:P09884; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000101868; -.
DR   CleanEx; HS_POLA1; -.
DR   ExpressionAtlas; P09884; baseline and differential.
DR   Genevisible; P09884; HS.
DR   GO; GO:0005658; C:alpha DNA polymerase:primase complex; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0008408; F:3'-5' exonuclease activity; IEA:InterPro.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0001882; F:nucleoside binding; IEA:InterPro.
DR   GO; GO:0000166; F:nucleotide binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IDA:UniProtKB.
DR   GO; GO:0006260; P:DNA replication; IMP:UniProtKB.
DR   GO; GO:0006270; P:DNA replication initiation; IDA:UniProtKB.
DR   GO; GO:0006269; P:DNA replication, synthesis of RNA primer; IEA:GOC.
DR   GO; GO:0006271; P:DNA strand elongation involved in DNA replication; IMP:UniProtKB.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; IMP:UniProtKB.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0006273; P:lagging strand elongation; IDA:UniProtKB.
DR   GO; GO:0006272; P:leading strand elongation; IDA:UniProtKB.
DR   GO; GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0000722; P:telomere maintenance via recombination; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.420.10; -; 1.
DR   Gene3D; 3.90.1600.10; -; 1.
DR   InterPro; IPR006172; DNA-dir_DNA_pol_B.
DR   InterPro; IPR017964; DNA-dir_DNA_pol_B_CS.
DR   InterPro; IPR006133; DNA-dir_DNA_pol_B_exonuc.
DR   InterPro; IPR006134; DNA-dir_DNA_pol_B_multi_dom.
DR   InterPro; IPR024647; DNA_pol_a_cat_su_N.
DR   InterPro; IPR023211; DNA_pol_palm_dom.
DR   InterPro; IPR029702; POLA/Pol1.
DR   InterPro; IPR012337; RNaseH-like_dom.
DR   InterPro; IPR015088; Znf_DNA-dir_DNA_pol_B_alpha.
DR   PANTHER; PTHR10322:SF29; PTHR10322:SF29; 1.
DR   Pfam; PF12254; DNA_pol_alpha_N; 1.
DR   Pfam; PF00136; DNA_pol_B; 1.
DR   Pfam; PF03104; DNA_pol_B_exo1; 1.
DR   Pfam; PF08996; zf-DNA_Pol; 1.
DR   PRINTS; PR00106; DNAPOLB.
DR   SMART; SM00486; POLBc; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS00116; DNA_POLYMERASE_B; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Acetylation; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; DNA replication; DNA-binding;
KW   DNA-directed DNA polymerase; Host-virus interaction; Iron;
KW   Iron-sulfur; Metal-binding; Nucleotidyltransferase; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase; Zinc;
KW   Zinc-finger.
FT   CHAIN         1   1462       DNA polymerase alpha catalytic subunit.
FT                                /FTId=PRO_0000046428.
FT   ZN_FING    1283   1315       CysA-type.
FT   REGION      650    715       DNA-binding region. {ECO:0000255}.
FT   REGION     1245   1376       DNA-binding region. {ECO:0000255}.
FT   MOTIF      1348   1374       CysB motif.
FT   COMPBIAS     75    112       Asp-rich.
FT   COMPBIAS   1047   1050       Poly-Leu.
FT   COMPBIAS   1051   1054       Poly-Lys.
FT   METAL      1283   1283       Zinc. {ECO:0000250}.
FT   METAL      1286   1286       Zinc. {ECO:0000250}.
FT   METAL      1310   1310       Zinc. {ECO:0000250}.
FT   METAL      1315   1315       Zinc. {ECO:0000250}.
FT   METAL      1348   1348       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   METAL      1353   1353       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   METAL      1371   1371       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   METAL      1374   1374       Iron-sulfur (4Fe-4S). {ECO:0000250}.
FT   SITE        124    125       Cleavage.
FT   MOD_RES     174    174       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     186    186       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     190    190       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     209    209       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     224    224       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P33609}.
FT   MOD_RES     406    406       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     970    970       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P33609}.
FT   VARIANT     740    740       Y -> H (in dbSNP:rs2230927).
FT                                /FTId=VAR_048877.
FT   CONFLICT    503    506       SPQL -> KSTA (in Ref. 1; CAA29920).
FT                                {ECO:0000305}.
FT   CONFLICT    837    837       A -> G (in Ref. 1; CAA29920).
FT                                {ECO:0000305}.
FT   CONFLICT   1405   1405       L -> C (in Ref. 4; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1426   1426       V -> C (in Ref. 4; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND      340    350       {ECO:0000244|PDB:4QCL}.
FT   TURN        352    354       {ECO:0000244|PDB:4QCL}.
FT   STRAND      359    367       {ECO:0000244|PDB:4QCL}.
FT   HELIX       368    370       {ECO:0000244|PDB:4QCL}.
FT   STRAND      372    380       {ECO:0000244|PDB:4QCL}.
FT   STRAND      385    391       {ECO:0000244|PDB:4QCL}.
FT   STRAND      393    396       {ECO:0000244|PDB:4QCL}.
FT   TURN        398    400       {ECO:0000244|PDB:4QCL}.
FT   STRAND      403    407       {ECO:0000244|PDB:4QCL}.
FT   HELIX       410    419       {ECO:0000244|PDB:4QCL}.
FT   HELIX       421    425       {ECO:0000244|PDB:4QCL}.
FT   STRAND      431    438       {ECO:0000244|PDB:4QCL}.
FT   STRAND      441    445       {ECO:0000244|PDB:5IUD}.
FT   STRAND      448    457       {ECO:0000244|PDB:4QCL}.
FT   STRAND      471    477       {ECO:0000244|PDB:4QCL}.
FT   HELIX       483    491       {ECO:0000244|PDB:4QCL}.
FT   STRAND      495    503       {ECO:0000244|PDB:4QCL}.
FT   STRAND      512    522       {ECO:0000244|PDB:4QCL}.
FT   HELIX       523    525       {ECO:0000244|PDB:4QCL}.
FT   STRAND      526    529       {ECO:0000244|PDB:4QCL}.
FT   STRAND      537    548       {ECO:0000244|PDB:4QCL}.
FT   STRAND      550    552       {ECO:0000244|PDB:4QCL}.
FT   STRAND      555    568       {ECO:0000244|PDB:4QCL}.
FT   STRAND      570    572       {ECO:0000244|PDB:4QCL}.
FT   STRAND      576    578       {ECO:0000244|PDB:4QCL}.
FT   STRAND      580    586       {ECO:0000244|PDB:4QCL}.
FT   HELIX       598    605       {ECO:0000244|PDB:4QCL}.
FT   STRAND      609    611       {ECO:0000244|PDB:4QCL}.
FT   HELIX       615    629       {ECO:0000244|PDB:4QCL}.
FT   STRAND      632    638       {ECO:0000244|PDB:4QCL}.
FT   TURN        639    642       {ECO:0000244|PDB:4QCL}.
FT   HELIX       643    653       {ECO:0000244|PDB:4QCL}.
FT   HELIX       659    662       {ECO:0000244|PDB:4QCL}.
FT   STRAND      663    665       {ECO:0000244|PDB:4QCL}.
FT   HELIX       679    684       {ECO:0000244|PDB:4QCL}.
FT   TURN        685    687       {ECO:0000244|PDB:4QCL}.
FT   STRAND      688    692       {ECO:0000244|PDB:4QCL}.
FT   HELIX       693    700       {ECO:0000244|PDB:4QCL}.
FT   HELIX       708    716       {ECO:0000244|PDB:4QCL}.
FT   HELIX       725    732       {ECO:0000244|PDB:4QCL}.
FT   HELIX       735    758       {ECO:0000244|PDB:4QCL}.
FT   HELIX       761    772       {ECO:0000244|PDB:4QCL}.
FT   HELIX       776    779       {ECO:0000244|PDB:4QCL}.
FT   HELIX       785    798       {ECO:0000244|PDB:4QCL}.
FT   STRAND      850    852       {ECO:0000244|PDB:4QCL}.
FT   STRAND      856    861       {ECO:0000244|PDB:4QCL}.
FT   HELIX       864    871       {ECO:0000244|PDB:4QCL}.
FT   TURN        876    878       {ECO:0000244|PDB:4QCL}.
FT   HELIX       910    930       {ECO:0000244|PDB:4QCL}.
FT   STRAND      931    933       {ECO:0000244|PDB:4QCL}.
FT   HELIX       936    960       {ECO:0000244|PDB:4QCL}.
FT   HELIX       970    993       {ECO:0000244|PDB:4QCL}.
FT   STRAND      997   1000       {ECO:0000244|PDB:4QCL}.
FT   STRAND     1002   1009       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1015   1030       {ECO:0000244|PDB:4QCL}.
FT   STRAND     1038   1051       {ECO:0000244|PDB:4QCL}.
FT   STRAND     1054   1062       {ECO:0000244|PDB:4QCL}.
FT   STRAND     1068   1076       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1078   1080       {ECO:0000244|PDB:4QCL}.
FT   STRAND     1082   1084       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1086   1099       {ECO:0000244|PDB:4QCL}.
FT   STRAND     1101   1103       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1105   1125       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1130   1133       {ECO:0000244|PDB:4QCL}.
FT   STRAND     1135   1138       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1143   1145       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1149   1151       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1153   1164       {ECO:0000244|PDB:4QCL}.
FT   STRAND     1165   1167       {ECO:0000244|PDB:4QCL}.
FT   STRAND     1174   1181       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1188   1190       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1195   1200       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1208   1214       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1216   1224       {ECO:0000244|PDB:4QCL}.
FT   STRAND     1225   1227       {ECO:0000244|PDB:5IUD}.
FT   HELIX      1232   1238       {ECO:0000244|PDB:4QCL}.
FT   HELIX      1269   1272       {ECO:0000244|PDB:4Y97}.
FT   TURN       1273   1275       {ECO:0000244|PDB:4Y97}.
FT   STRAND     1279   1282       {ECO:0000244|PDB:4Y97}.
FT   TURN       1284   1286       {ECO:0000244|PDB:4Y97}.
FT   STRAND     1289   1298       {ECO:0000244|PDB:4Y97}.
FT   HELIX      1319   1322       {ECO:0000244|PDB:4Y97}.
FT   HELIX      1323   1342       {ECO:0000244|PDB:4Y97}.
FT   STRAND     1346   1349       {ECO:0000244|PDB:4Y97}.
FT   TURN       1351   1353       {ECO:0000244|PDB:4Y97}.
FT   STRAND     1356   1358       {ECO:0000244|PDB:4Y97}.
FT   STRAND     1359   1362       {ECO:0000244|PDB:1K18}.
FT   STRAND     1364   1367       {ECO:0000244|PDB:1N5G}.
FT   STRAND     1368   1370       {ECO:0000244|PDB:4Y97}.
FT   STRAND     1372   1383       {ECO:0000244|PDB:4Y97}.
FT   HELIX      1385   1397       {ECO:0000244|PDB:4Y97}.
FT   HELIX      1401   1406       {ECO:0000244|PDB:4Y97}.
FT   HELIX      1411   1420       {ECO:0000244|PDB:4Y97}.
FT   HELIX      1424   1434       {ECO:0000244|PDB:4Y97}.
SQ   SEQUENCE   1462 AA;  165913 MW;  DC40C3EDD6F4B495 CRC64;
     MAPVHGDDSL SDSGSFVSSR ARREKKSKKG RQEALERLKK AKAGEKYKYE VEDFTGVYEE
     VDEEQYSKLV QARQDDDWIV DDDGIGYVED GREIFDDDLE DDALDADEKG KDGKARNKDK
     RNVKKLAVTK PNNIKSMFIA CAGKKTADKA VDLSKDGLLG DILQDLNTET PQITPPPVMI
     LKKKRSIGAS PNPFSVHTAT AVPSGKIASP VSRKEPPLTP VPLKRAEFAG DDVQVESTEE
     EQESGAMEFE DGDFDEPMEV EEVDLEPMAA KAWDKESEPA EEVKQEADSG KGTVSYLGSF
     LPDVSCWDID QEGDSSFSVQ EVQVDSSHLP LVKGADEEQV FHFYWLDAYE DQYNQPGVVF
     LFGKVWIESA ETHVSCCVMV KNIERTLYFL PREMKIDLNT GKETGTPISM KDVYEEFDEK
     IATKYKIMKF KSKPVEKNYA FEIPDVPEKS EYLEVKYSAE MPQLPQDLKG ETFSHVFGTN
     TSSLELFLMN RKIKGPCWLE VKSPQLLNQP VSWCKVEAMA LKPDLVNVIK DVSPPPLVVM
     AFSMKTMQNA KNHQNEIIAM AALVHHSFAL DKAAPKPPFQ SHFCVVSKPK DCIFPYAFKE
     VIEKKNVKVE VAATERTLLG FFLAKVHKID PDIIVGHNIY GFELEVLLQR INVCKAPHWS
     KIGRLKRSNM PKLGGRSGFG ERNATCGRMI CDVEISAKEL IRCKSYHLSE LVQQILKTER
     VVIPMENIQN MYSESSQLLY LLEHTWKDAK FILQIMCELN VLPLALQITN IAGNIMSRTL
     MGGRSERNEF LLLHAFYENN YIVPDKQIFR KPQQKLGDED EEIDGDTNKY KKGRKKAAYA
     GGLVLDPKVG FYDKFILLLD FNSLYPSIIQ EFNICFTTVQ RVASEAQKVT EDGEQEQIPE
     LPDPSLEMGI LPREIRKLVE RRKQVKQLMK QQDLNPDLIL QYDIRQKALK LTANSMYGCL
     GFSYSRFYAK PLAALVTYKG REILMHTKEM VQKMNLEVIY GDTDSIMINT NSTNLEEVFK
     LGNKVKSEVN KLYKLLEIDI DGVFKSLLLL KKKKYAALVV EPTSDGNYVT KQELKGLDIV
     RRDWCDLAKD TGNFVIGQIL SDQSRDTIVE NIQKRLIEIG ENVLNGSVPV SQFEINKALT
     KDPQDYPDKK SLPHVHVALW INSQGGRKVK AGDTVSYVIC QDGSNLTASQ RAYAPEQLQK
     QDNLTIDTQY YLAQQIHPVV ARICEPIDGI DAVLIATWLG LDPTQFRVHH YHKDEENDAL
     LGGPAQLTDE EKYRDCERFK CPCPTCGTEN IYDNVFDGSG TDMEPSLYRC SNIDCKASPL
     TFTVQLSNKL IMDIRRFIKK YYDGWLICEE PTCRNRTRHL PLQFSRTGPL CPACMKATLQ
     PEYSDKSLYT QLCFYRYIFD AECALEKLTT DHEKDKLKKQ FFTPKVLQDY RKLKNTAEQF
     LSRSGYSEVN LSKLFAGCAV KS
//
